SlideShare a Scribd company logo
“Fit to stick” Innovation
 and Implementation in
       Health Care
           This PPT and other resources from
             http://public.me.com/johnovr

or https://www.idrive.com - see references at end of
               John Øvretveit,
                        PPT
      Director of Research, Professor of Health Innovation and
      Evaluation, Karolinska Institutet, Stockholm, Sweden

                                                             3/2/2012
                                                                        1
Outcomes

 1) Describe what research shows about
 moving from Phase 1 single project test to
 Phase 2 limited spread and beyond
 (P1//P2 chasm)
 2) Describe what research is missing
  and methods and changes to provide
      practitioners (at all levels)
  with research-informed guidance      2
3/2/2012
The problem: we know more about what works
          than how to put it into routine services
  Proven effective treatments, practices & service deliver
      models
        Slow and patchy uptake in services
        Significant avoidable suffering and costs
        …because there is some knowledge about
       how to put these effective interventions into service
  Research problems
        Under-developed methods for finding and developing
           effective implementation and spread approaches
        Knowledge about what works not known to practitioners3
3/2/2012
Examples Ph1                                   //Ph2
chasm

Type 1 First local test         Findings - Low cost good
                                 detection allowed follow-up
Automatic telephone
                                 treatment resulting in better
assessment for depression in
                                 adherence and less ultilisation
diabetes in one PHC
                                Presented by team at network
                                 meeting & promise of support
                                Rapid take-up local PHCs but
                                 no spread beyond


                                                            4
Examples Ph1                                   //Ph2
chasm

Type 2 One site trial           Findings – Same but with
                                 comparison group
Same but trial
                                     - more certainty
- Automatic telephone
assessment for depression in    Published
diabetes in one PHC vs usual
                                No one took any notice
care in another PHC
                                After research funding
                                 finished, no budget or time for
                                 system and follow-up

                                                           5
Examples Ph1                                    //Ph2
chasm

Type 3 Many site trial.         Findings – additional study
                                 found discrepancies between
 Same but in 90 PCHs with
                                 telephone and expert panel
  90 matched in 2 regions
                                 assessment of depression
- Automatic telephone
                                Comparable reductions in
assessment for depression in
                                 ultilisation
diabetes in 90 PHC vs usual
care in 90 PHC                  Published
                                No one took any notice
                                After research funding
                                                           6
                                 finished, no budget or time for
                                 system and follow-up
What explains?


Type 1 First local test         Limited evidence,

Spread locally                 But

Automatic telephone             Enthusiasm and free support
assessment for depression in     offered by team.
diabetes in one PHC             Low cost offer by telephone
                                 service
But not beyond
                                Charismatic trio of medical
                                 leader, nurse and social
                                 worker
                                                         7
                                Sympathetic local leaders
What explains?


Type 2 One site trial    Stronger evidence
Same but trial
                         Practitioners do not
                         read scientific IT
                         journals
                         No “push” by pioneers
                          or others


                                              8
What explains?


Type 3 Many site trial.    Questions about
 Same but in many PCHs     sensitivity and specificity
                            of telephone
                            assessment
                           No practitoners read
                            about it
                           No push, no funding.

                                                   9
Johns theory based on reviews and
                  experience”
 Some things spread rapidly
   Clinician interest/patient demand (minimally invasiev
    surgery)
   Compelling cost savings (automated testing path)
 Some slowly, in patches
   Support to prevent admission of high users
                                                   Which
 Some proven but very low uptake                  Ones?
   Do not spread straight from the “research fridge”
                                                   Why?
 Some in spite of –ve evidence                        1
   Smart IV pumps in ICU (Nuckols et al 2007)         0
Research based theory – simple summary
  Seed     Gardener/planting & nurture     Climate / soil




Product         Push>                    <Pull

                                         3/2/2012           11
Bridging the P1 / / P2 chasm
  Product
        Features of the new better intervention
        Comes with credible evidence of effectiveness

  Push
        Marketing and support

  Pull
        Services experience a problem this can solve
        It fits with values and “makes sense”
        Services are capable of adopting and sustaining it - 1
3/2/2012
           resources                                         2
Bridging the P2 / / P3 chasm
                        Glen Allen, Virginia - Google Maps



                                                             Address



  From a number of services (P2) to 70%
      regional or national coverage with >50%
      adoption of intervention (P3)
  Which is most critical here? Vote, 1,2,3
 1)Product?
 2)Push?
 3)Pull?
                                                                       1
3/2/2012
                                                                       3
What help can research give to “Chasm-
                Bridgers”?
1 Research based assessment ool – HRET
2 Concepts - Ways of thinking about what and how
to spread
3 Categorisation of implementation/spread
approaches


                                            1
                                            4
1 Research based assessment tool – HRET




                                   1
                                   5
Sections HRET Spread Assessment Tool
 Environmental Factors
 Innovation Factors
 Target Audience Factors
 Organizational Factors
Spread Readiness Scale:
 101-125 Organic, Natural Spread
 76-100 Promising Spread Initiative
 51 – 75 Challenging Spread Initiative
                                           1
 <50 Doomed, Focus on Underlying Issues
                                           6
Research into implementation “approaches”
            Progress so far…
Conceptualisation – are there different “approaches”
and how do we define/describe?
Concepts 1: distinction between
a) Treatment and service delivery interventions
     from
b) Implementation - what done to enable providers
to change
 Note: distinction not useful when implementation
  involves iterative adaption - testing & revision of
                                                       17
  intervention (intervention not already proven locally)
Example of intervention content

Eg CLABSI Bundle:
1 Wash your hands.
2 Clean skin
 with chlorhexidine.
3. Use maximal barrier
precautions.
4. Avoid the femoral site.
5. Ask daily whether
the benefits of the line
exceed the risks.                              1
                                               8
Example of Implementation “approach”

 Breakthrough collaborative eg Michigan Keystone:




                                                    1
3/2/2012
                                                    9
Three Elements
Collaborative breakthrough programme
 Structure:
   Groups and accountability 3 levels: 1regional collaborative
    organisers, 2 local management, 3 local project team
 Systems:
   Project team measurement and feedback
   Regional support
 Steps/methods
   Planning, learning sessions & calls, post-collaborative
   To plan and change local service, test and revise         2
                                                              0
Implementation approach = “3S” combination
                    of:
1 Structure:
  who is going to help this happen and by when:
   roles, responsibility, time, accountability
2 Systems:
  measurement and feedback
3 Systematic Steps:
  methods, actions = systematic ways to enable
                                                 2
   change
                                                 1
Different ways of classifying 3) Systematic Step methods?
  Professional; Financial strategies; Organizational
      strategies. Or guidelines (Hysong 2011)




                                                   2
3/2/2012
                                                   2
.
 So implementation does not just happen? You have
 to have an infrastructure?
  Current channels – professions limited impact, regulation
      more, financial penalties and rewards - more still.

 Concepts 3:
  Specific intervention implementation infrastructure (eg
   time limited collaborative for X)
  Generic implementation infrastructure : to support any
   project and continual change
  (eg IMC research unit, KP performance improvement   2
   units, VA systems design and some QUERI centres)3
3/2/2012
Concepts 4: Alignment of context influences
  Infrastructure may involve “influencers”
   which act on different levels of health
   system
  to get the influences at each level to align
 Eg for CLABSI or readmission
  Need “alignment adjusters” to identify influences
   countering X change and to “sheep dog” the influences
  Theory: aligned actions by different levels may be more
                                                       2
   effective (but feasible?) (context to help implementation)
3/2/2012
                                                       4
Is this conception of “intervention approach”-
(structure, systems, steps/methods) a theory then?
 What do you think - YES? No?
 Yes – based on observation of collaborative and other
 intentional systematic improvement programmes
 Predictive theory - untested
  Hypothesis in play in this field:
 H1: Some implementation approaches are more
 suited to some interventions than others
  (the “intervention/implementation match” for
   effective sustained change)                         2
3/2/2012
                                                      5
H1: Match intervention to implementation
                          approach
 eg if aim to change individual physician prescribing
 behaviour, then this implementation approach more
 effective than a collaborative:
  Structure: nationally credible researchers, local
   physician opinion leaders and champions, peer
   project teams, academic detailers.
  Systems: credible existing data banks on
   prescribing
  Systematic steps: training, feedback, academic2
   detailing.                                       6
3/2/2012
H1: Match intervention to implementation
                          approach
  If implementing a clinical decision support system
      in an EMR:
  Structure: project team, steering committee, senior
   management sub-group
  Systems: Measurement and feedback
  Systematic steps: Methods: phased testing, flexiblity in
   standard screens, etc

  If implementing a chronic care model then…. 2
3/2/2012
                                                         7
H2 : Context match to intervention and
                 implementation approach
  Is there a “fit”, and is it “fit to stick”
  Internal context:
      Advances values, norms, objectives, &
      priorities
  External context:
        Compatible with regulations, financing and
           directives                           2
3/2/2012
                                                8
Part 3 Research Agenda and Methods
 Covers 3 subjects:
 Practitioners have questions we are not
 addressing – next
 Methods for providing research based
 answers
 What are the challenges for us

                                       2
3/2/2012
                                       9
Practitioners want this information:
  Description: What was the implementation
   approach?
      (and the intervention content)
  Cost effectiveness: Did it acheive the change cost-
      effectively?
      (and did the intervention change reduce costs and make a
      difference for patients?)
  Replicability: in which situations would we expect
   similar results
                                                  3
  and which principles should guide design of the0
   implementation approach in other situations?
3/2/2012
Three research strategies
 1 Parallel process and outcome-
 effectiveness evaluations
 2 Theory-based testing or model-
 revising
 3 Integrated research-implementation
 evaluation
                                        3
 See March 8th Cyber seminar
3/2/2012
                                        1
Challenges
 Attitude – practical questions not real science
 and wont get published – can’t serve two
 masters
 Skills to use the methods
 New research practice
      Practice based – engaged partnership research
 Academic promotion and reviewers
 Financing
 Shift of financing and reviewers to be more 3
 accepting                                   2
3/2/2012
Conclusions
Each person write down and then share in the group:
1. These were the main points…


2. This was new or surprising, for me…


3. The most useful idea for my work was…


4. What I would like to find out more about…



                                            3/2/2012
                                                       33
Resources

                       3
3/2/2012
                       4
Resources on Johns web site folder
  http://public.me.com/johnovr
  .




                                                3
3/2/2012
                                                5
Resources on Johns web site folder
  http://public.me.com/johnovr
  Or or https://www.idrive.com - see references at end of PPT
 Download files from idrive by going to web site:
 http://www.idrive.com/;
  Log in user = jovr pass= anna. THEN use the search field on
      the right to enter in a word realated to the subject. You will
      see files on this subject – click on the file you want to
      download, after entering anna and it will download to
      your computer.
                                                                3
3/2/2012
                                                                6
References.

  .




                         3
3/2/2012
                         7
DETAILS

                     3
3/2/2012
                     8
BANK 1mar

                       3
3/2/2012
                       9
.


  Few interventions and innovations are able to cross the
      project//spread chasm. The fit between the innovation
      and the adopting service appears critical, but the
      paradox is that if it fits too well and is likely to be
      adopted with minor disruption, it may not make much
      improvement or be much of an innovation. This seminar
      considers issues in moving an innovation from pilot to
      phase 1 and phase 2 scale up stages, and ways to carry
      out actionable research into the strategies, structure4 and
      steps for spread.
3/2/2012
                                                            0
It has to be local because
 10% of success is local personalities
 20% of success is using a change proven elsewhere to
  improve quality and reduce costs
 30% is your implementation (do you have skills, project
  team capacity, experience?)
 40% is nothing to do with you -
   whether your context enables implementation and rewards
    value improvements
     Do you get paid for a diagnosis of patient admitted 5 days after
      discharge with AC SYSTOLIC HRT FAILURE (2008 ICD-9-CM
      Diagnosis Code 428.21)?                                    4
                                                                1
     I patient diagnoised with above during stay – do you get paid?
Johns theory based on reviews and
                  experience”
 Some things spread rapidly
   Clinician interest/patient demand (minimally invasiev
    surgery)
   Compelling cost savings (automated testing path)
 Some slowly, in patches
   Support to prevent admission of high users
                                                   Which
 Some proven but very low uptake                  Ones?
   Do not spread straight from the “research fridge”
                                                   Why?
 Some in spite of –ve evidence                        4
   Smart IV pumps in ICU (Nuckols et al 2007)         2
The research issues
    We know less about how to put it into
widespread practice… than about what works
  Missing, Methods, Attitude/motivation, rewards incentives
      structure




                                                        4
3/2/2012
                                                        3
Knowledge Translation to everyday clinical practice

K Basic
BioMedical                                              K Treatment
Science               K Efficacy                        Effectiveness
                      In controlled                     range of patients
                      situation with
   Translation 1      specific patients
   Intervention to             Translation 2
   patients                    Intervention to range                  K Implementation
   RCTs on patients            of patients in                         Effectiveness range of
                               different settings                     providers to use treatment
                               RCTs or controlled trials on
                               patients
                                                                 Translation 3
                                                                 Intervention to
                                                                 providers to use the
                                                                 treatment
                                                                 RCTs or controlled trials on
          Oh, that life were so simple!                          providers
                                                                 Non-experimental research
                                                                 designs
.

  .




               4
3/2/2012
               5
.

  .




               4
3/2/2012
               6
Conclusions
Each person write down and then share in the group:
1. These were the main points…


2. This was new or surprising, for me…


3. The most useful idea for my work was…


4. What I would like to find out more about…



                                            3/2/2012
                                                       47

More Related Content

Viewers also liked

CCAFS Strategy for Latin America
CCAFS Strategy for Latin AmericaCCAFS Strategy for Latin America
TEMA 4- Proyecto investigación
TEMA 4- Proyecto investigaciónTEMA 4- Proyecto investigación
TEMA 4- Proyecto investigación
Mónika Díaz-Vega Pando
 
Asesoria malaga
Asesoria malagaAsesoria malaga
Asesoria malaga
fq Asesores
 
Unit 8. Devices that generate meaning, construct reality and shape identity. ...
Unit 8. Devices that generate meaning, construct reality and shape identity. ...Unit 8. Devices that generate meaning, construct reality and shape identity. ...
Unit 8. Devices that generate meaning, construct reality and shape identity. ...
Nadia Gabriela Dresscher
 
20150226_Infoday H2020_Energía_María Luisa Revilla
20150226_Infoday H2020_Energía_María Luisa Revilla20150226_Infoday H2020_Energía_María Luisa Revilla
20150226_Infoday H2020_Energía_María Luisa Revilla
Redit
 
Bases Portatil Dell
Bases Portatil DellBases Portatil Dell
Bases Portatil Delldiegops
 
Presentación de servicios CORAOPS 2014
Presentación de servicios CORAOPS 2014Presentación de servicios CORAOPS 2014
Presentación de servicios CORAOPS 2014
Instituto de Coaching Ejecutivo CORAOPS
 
High Security Zones and the Righ to Return and Restitution in Sri Lanka
High Security Zones and the Righ to Return and Restitution in Sri LankaHigh Security Zones and the Righ to Return and Restitution in Sri Lanka
High Security Zones and the Righ to Return and Restitution in Sri LankaSanda Wijeratne
 
Estudio de Oferta Exportadora de la Industria Metalmecánica PYME de Mendoza y...
Estudio de Oferta Exportadora de la Industria Metalmecánica PYME de Mendoza y...Estudio de Oferta Exportadora de la Industria Metalmecánica PYME de Mendoza y...
Estudio de Oferta Exportadora de la Industria Metalmecánica PYME de Mendoza y...
ASINMET Mendoza
 
Producto 10 despierta baby
Producto 10 despierta babyProducto 10 despierta baby
Producto 10 despierta baby
jose15calderon
 
IbO Software de Innovación por Objetivos Empresas
IbO Software de Innovación por Objetivos EmpresasIbO Software de Innovación por Objetivos Empresas
IbO Software de Innovación por Objetivos Empresas
JuanCAC
 
Email marketing and Science of Storytelling
Email marketing and Science of StorytellingEmail marketing and Science of Storytelling
Email marketing and Science of Storytelling
Juvlon Email Marketing
 
IRP for Dummies
IRP for DummiesIRP for Dummies
IRP for Dummies
Wayne Stacey
 
Bedeutung von Markenartikeln für Senioren - 3 Fragen an Alexander Wild
Bedeutung von Markenartikeln für Senioren - 3 Fragen an Alexander WildBedeutung von Markenartikeln für Senioren - 3 Fragen an Alexander Wild
Bedeutung von Markenartikeln für Senioren - 3 Fragen an Alexander Wild
Feier@bend Online Dienste für Senioren AG
 
Indian Homoeopathic Medical Association-IHMA by Dr. Kabita Mishra BHMS
Indian Homoeopathic Medical Association-IHMA by Dr. Kabita Mishra BHMSIndian Homoeopathic Medical Association-IHMA by Dr. Kabita Mishra BHMS
Indian Homoeopathic Medical Association-IHMA by Dr. Kabita Mishra BHMS
Dr. Kabita Mishra
 

Viewers also liked (20)

CCAFS Strategy for Latin America
CCAFS Strategy for Latin AmericaCCAFS Strategy for Latin America
CCAFS Strategy for Latin America
 
Ingenieur_RvS
Ingenieur_RvSIngenieur_RvS
Ingenieur_RvS
 
TEMA 4- Proyecto investigación
TEMA 4- Proyecto investigaciónTEMA 4- Proyecto investigación
TEMA 4- Proyecto investigación
 
Asesoria malaga
Asesoria malagaAsesoria malaga
Asesoria malaga
 
Unit 8. Devices that generate meaning, construct reality and shape identity. ...
Unit 8. Devices that generate meaning, construct reality and shape identity. ...Unit 8. Devices that generate meaning, construct reality and shape identity. ...
Unit 8. Devices that generate meaning, construct reality and shape identity. ...
 
News med
News medNews med
News med
 
20150226_Infoday H2020_Energía_María Luisa Revilla
20150226_Infoday H2020_Energía_María Luisa Revilla20150226_Infoday H2020_Energía_María Luisa Revilla
20150226_Infoday H2020_Energía_María Luisa Revilla
 
Bases Portatil Dell
Bases Portatil DellBases Portatil Dell
Bases Portatil Dell
 
Mediamax
MediamaxMediamax
Mediamax
 
Presentación de servicios CORAOPS 2014
Presentación de servicios CORAOPS 2014Presentación de servicios CORAOPS 2014
Presentación de servicios CORAOPS 2014
 
Shopping
ShoppingShopping
Shopping
 
High Security Zones and the Righ to Return and Restitution in Sri Lanka
High Security Zones and the Righ to Return and Restitution in Sri LankaHigh Security Zones and the Righ to Return and Restitution in Sri Lanka
High Security Zones and the Righ to Return and Restitution in Sri Lanka
 
Estudio de Oferta Exportadora de la Industria Metalmecánica PYME de Mendoza y...
Estudio de Oferta Exportadora de la Industria Metalmecánica PYME de Mendoza y...Estudio de Oferta Exportadora de la Industria Metalmecánica PYME de Mendoza y...
Estudio de Oferta Exportadora de la Industria Metalmecánica PYME de Mendoza y...
 
Producto 10 despierta baby
Producto 10 despierta babyProducto 10 despierta baby
Producto 10 despierta baby
 
IbO Software de Innovación por Objetivos Empresas
IbO Software de Innovación por Objetivos EmpresasIbO Software de Innovación por Objetivos Empresas
IbO Software de Innovación por Objetivos Empresas
 
Email marketing and Science of Storytelling
Email marketing and Science of StorytellingEmail marketing and Science of Storytelling
Email marketing and Science of Storytelling
 
valladolid desde el aire,,,,,,,,espectacular
valladolid desde el aire,,,,,,,,espectacularvalladolid desde el aire,,,,,,,,espectacular
valladolid desde el aire,,,,,,,,espectacular
 
IRP for Dummies
IRP for DummiesIRP for Dummies
IRP for Dummies
 
Bedeutung von Markenartikeln für Senioren - 3 Fragen an Alexander Wild
Bedeutung von Markenartikeln für Senioren - 3 Fragen an Alexander WildBedeutung von Markenartikeln für Senioren - 3 Fragen an Alexander Wild
Bedeutung von Markenartikeln für Senioren - 3 Fragen an Alexander Wild
 
Indian Homoeopathic Medical Association-IHMA by Dr. Kabita Mishra BHMS
Indian Homoeopathic Medical Association-IHMA by Dr. Kabita Mishra BHMSIndian Homoeopathic Medical Association-IHMA by Dr. Kabita Mishra BHMS
Indian Homoeopathic Medical Association-IHMA by Dr. Kabita Mishra BHMS
 

Similar to Ovret innovation and implementation in health care

EBM for Haematology - Workshop 5
EBM for Haematology - Workshop 5EBM for Haematology - Workshop 5
EBM for Haematology - Workshop 5Robin Featherstone
 
Publication bias in service delivery research: a critique - John Ovretveit
Publication bias in service delivery research: a critique - John OvretveitPublication bias in service delivery research: a critique - John Ovretveit
Publication bias in service delivery research: a critique - John Ovretveit
NIHR CLAHRC West Midlands
 
Resident Presentations - Evidence-Based Medicine for Haematology
Resident Presentations - Evidence-Based Medicine for HaematologyResident Presentations - Evidence-Based Medicine for Haematology
Resident Presentations - Evidence-Based Medicine for Haematology
Robin Featherstone
 
ICN Victoria: Gantner on "Translating Research into Practice"
ICN Victoria: Gantner on "Translating Research into Practice"ICN Victoria: Gantner on "Translating Research into Practice"
ICN Victoria: Gantner on "Translating Research into Practice"
Intensive Care Network Victoria
 
Strategies for Improving Laboratory Utilization
Strategies for Improving Laboratory Utilization Strategies for Improving Laboratory Utilization
Strategies for Improving Laboratory Utilization
Ola Elgaddar
 
2012 02 16 - Clinical LOINC Tutorial - Collections - Panels Forms and Assessm...
2012 02 16 - Clinical LOINC Tutorial - Collections - Panels Forms and Assessm...2012 02 16 - Clinical LOINC Tutorial - Collections - Panels Forms and Assessm...
2012 02 16 - Clinical LOINC Tutorial - Collections - Panels Forms and Assessm...dvreeman
 
1115 wyatt wheres the science in hi for christchurch nz oct 2015
1115 wyatt wheres the science in hi   for christchurch nz oct 20151115 wyatt wheres the science in hi   for christchurch nz oct 2015
1115 wyatt wheres the science in hi for christchurch nz oct 2015Health Informatics New Zealand
 
NELC-POCT20120930a
NELC-POCT20120930aNELC-POCT20120930a
NELC-POCT20120930aMark Gusack
 
Initial Medical Policy and Model Coverage Guidelines
Initial Medical Policy and Model Coverage GuidelinesInitial Medical Policy and Model Coverage Guidelines
Initial Medical Policy and Model Coverage Guidelines
Center for Medical Technology Policy
 
Epigen Biosciences I-Corps@NIH 121014
Epigen Biosciences I-Corps@NIH 121014Epigen Biosciences I-Corps@NIH 121014
Epigen Biosciences I-Corps@NIH 121014Stanford University
 
Clinical Trials Strategy: The Clinical Development Plan
Clinical Trials Strategy: The Clinical Development PlanClinical Trials Strategy: The Clinical Development Plan
Clinical Trials Strategy: The Clinical Development Plan
MaRS Discovery District
 
Intro To Adaptive Design
Intro To Adaptive DesignIntro To Adaptive Design
Intro To Adaptive Design
TechnomicsResearch
 
Bioanalytical validation personal perspective
Bioanalytical validation personal perspectiveBioanalytical validation personal perspective
Bioanalytical validation personal perspective
E. Dennis Bashaw
 
UKADC System Partners Meeting
UKADC System Partners MeetingUKADC System Partners Meeting
UKADC System Partners Meeting
Scott Buckler
 
CHW Review_various_10.12.12
CHW Review_various_10.12.12CHW Review_various_10.12.12
CHW Review_various_10.12.12CORE Group
 
Diagnostic error
Diagnostic errorDiagnostic error
Diagnostic error
EM OMSB
 
The Challenge of Evaluating Electronic Decision Support in the Community
The Challenge of Evaluating Electronic Decision Support in the CommunityThe Challenge of Evaluating Electronic Decision Support in the Community
The Challenge of Evaluating Electronic Decision Support in the Community
Health Informatics New Zealand
 
Feasibility Solutions to Clinical Trial Nightmares
Feasibility Solutions to Clinical Trial NightmaresFeasibility Solutions to Clinical Trial Nightmares
Feasibility Solutions to Clinical Trial Nightmares
jbarag
 
2011 08 15 - Clinical LOINC Tutorial - Collections - Panels Forms and Assessm...
2011 08 15 - Clinical LOINC Tutorial - Collections - Panels Forms and Assessm...2011 08 15 - Clinical LOINC Tutorial - Collections - Panels Forms and Assessm...
2011 08 15 - Clinical LOINC Tutorial - Collections - Panels Forms and Assessm...dvreeman
 
Impact Of a Clinical Decision Support Tool on Asthma Patients with Current As...
Impact Of a Clinical Decision Support Tool on Asthma Patients with Current As...Impact Of a Clinical Decision Support Tool on Asthma Patients with Current As...
Impact Of a Clinical Decision Support Tool on Asthma Patients with Current As...Yiscah Bracha
 

Similar to Ovret innovation and implementation in health care (20)

EBM for Haematology - Workshop 5
EBM for Haematology - Workshop 5EBM for Haematology - Workshop 5
EBM for Haematology - Workshop 5
 
Publication bias in service delivery research: a critique - John Ovretveit
Publication bias in service delivery research: a critique - John OvretveitPublication bias in service delivery research: a critique - John Ovretveit
Publication bias in service delivery research: a critique - John Ovretveit
 
Resident Presentations - Evidence-Based Medicine for Haematology
Resident Presentations - Evidence-Based Medicine for HaematologyResident Presentations - Evidence-Based Medicine for Haematology
Resident Presentations - Evidence-Based Medicine for Haematology
 
ICN Victoria: Gantner on "Translating Research into Practice"
ICN Victoria: Gantner on "Translating Research into Practice"ICN Victoria: Gantner on "Translating Research into Practice"
ICN Victoria: Gantner on "Translating Research into Practice"
 
Strategies for Improving Laboratory Utilization
Strategies for Improving Laboratory Utilization Strategies for Improving Laboratory Utilization
Strategies for Improving Laboratory Utilization
 
2012 02 16 - Clinical LOINC Tutorial - Collections - Panels Forms and Assessm...
2012 02 16 - Clinical LOINC Tutorial - Collections - Panels Forms and Assessm...2012 02 16 - Clinical LOINC Tutorial - Collections - Panels Forms and Assessm...
2012 02 16 - Clinical LOINC Tutorial - Collections - Panels Forms and Assessm...
 
1115 wyatt wheres the science in hi for christchurch nz oct 2015
1115 wyatt wheres the science in hi   for christchurch nz oct 20151115 wyatt wheres the science in hi   for christchurch nz oct 2015
1115 wyatt wheres the science in hi for christchurch nz oct 2015
 
NELC-POCT20120930a
NELC-POCT20120930aNELC-POCT20120930a
NELC-POCT20120930a
 
Initial Medical Policy and Model Coverage Guidelines
Initial Medical Policy and Model Coverage GuidelinesInitial Medical Policy and Model Coverage Guidelines
Initial Medical Policy and Model Coverage Guidelines
 
Epigen Biosciences I-Corps@NIH 121014
Epigen Biosciences I-Corps@NIH 121014Epigen Biosciences I-Corps@NIH 121014
Epigen Biosciences I-Corps@NIH 121014
 
Clinical Trials Strategy: The Clinical Development Plan
Clinical Trials Strategy: The Clinical Development PlanClinical Trials Strategy: The Clinical Development Plan
Clinical Trials Strategy: The Clinical Development Plan
 
Intro To Adaptive Design
Intro To Adaptive DesignIntro To Adaptive Design
Intro To Adaptive Design
 
Bioanalytical validation personal perspective
Bioanalytical validation personal perspectiveBioanalytical validation personal perspective
Bioanalytical validation personal perspective
 
UKADC System Partners Meeting
UKADC System Partners MeetingUKADC System Partners Meeting
UKADC System Partners Meeting
 
CHW Review_various_10.12.12
CHW Review_various_10.12.12CHW Review_various_10.12.12
CHW Review_various_10.12.12
 
Diagnostic error
Diagnostic errorDiagnostic error
Diagnostic error
 
The Challenge of Evaluating Electronic Decision Support in the Community
The Challenge of Evaluating Electronic Decision Support in the CommunityThe Challenge of Evaluating Electronic Decision Support in the Community
The Challenge of Evaluating Electronic Decision Support in the Community
 
Feasibility Solutions to Clinical Trial Nightmares
Feasibility Solutions to Clinical Trial NightmaresFeasibility Solutions to Clinical Trial Nightmares
Feasibility Solutions to Clinical Trial Nightmares
 
2011 08 15 - Clinical LOINC Tutorial - Collections - Panels Forms and Assessm...
2011 08 15 - Clinical LOINC Tutorial - Collections - Panels Forms and Assessm...2011 08 15 - Clinical LOINC Tutorial - Collections - Panels Forms and Assessm...
2011 08 15 - Clinical LOINC Tutorial - Collections - Panels Forms and Assessm...
 
Impact Of a Clinical Decision Support Tool on Asthma Patients with Current As...
Impact Of a Clinical Decision Support Tool on Asthma Patients with Current As...Impact Of a Clinical Decision Support Tool on Asthma Patients with Current As...
Impact Of a Clinical Decision Support Tool on Asthma Patients with Current As...
 

Recently uploaded

micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 

Recently uploaded (20)

micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 

Ovret innovation and implementation in health care

  • 1. “Fit to stick” Innovation and Implementation in Health Care This PPT and other resources from http://public.me.com/johnovr or https://www.idrive.com - see references at end of John Øvretveit, PPT Director of Research, Professor of Health Innovation and Evaluation, Karolinska Institutet, Stockholm, Sweden 3/2/2012 1
  • 2. Outcomes 1) Describe what research shows about moving from Phase 1 single project test to Phase 2 limited spread and beyond (P1//P2 chasm) 2) Describe what research is missing  and methods and changes to provide practitioners (at all levels)  with research-informed guidance 2 3/2/2012
  • 3. The problem: we know more about what works than how to put it into routine services  Proven effective treatments, practices & service deliver models  Slow and patchy uptake in services  Significant avoidable suffering and costs  …because there is some knowledge about how to put these effective interventions into service  Research problems  Under-developed methods for finding and developing effective implementation and spread approaches  Knowledge about what works not known to practitioners3 3/2/2012
  • 4. Examples Ph1 //Ph2 chasm Type 1 First local test  Findings - Low cost good detection allowed follow-up Automatic telephone treatment resulting in better assessment for depression in adherence and less ultilisation diabetes in one PHC  Presented by team at network meeting & promise of support  Rapid take-up local PHCs but no spread beyond 4
  • 5. Examples Ph1 //Ph2 chasm Type 2 One site trial  Findings – Same but with comparison group Same but trial - more certainty - Automatic telephone assessment for depression in  Published diabetes in one PHC vs usual  No one took any notice care in another PHC  After research funding finished, no budget or time for system and follow-up 5
  • 6. Examples Ph1 //Ph2 chasm Type 3 Many site trial.  Findings – additional study found discrepancies between  Same but in 90 PCHs with telephone and expert panel 90 matched in 2 regions assessment of depression - Automatic telephone  Comparable reductions in assessment for depression in ultilisation diabetes in 90 PHC vs usual care in 90 PHC  Published  No one took any notice  After research funding 6 finished, no budget or time for system and follow-up
  • 7. What explains? Type 1 First local test  Limited evidence, Spread locally But Automatic telephone  Enthusiasm and free support assessment for depression in offered by team. diabetes in one PHC  Low cost offer by telephone service But not beyond  Charismatic trio of medical leader, nurse and social worker 7  Sympathetic local leaders
  • 8. What explains? Type 2 One site trial  Stronger evidence Same but trial  Practitioners do not read scientific IT journals  No “push” by pioneers or others 8
  • 9. What explains? Type 3 Many site trial.  Questions about  Same but in many PCHs sensitivity and specificity of telephone assessment  No practitoners read about it  No push, no funding. 9
  • 10. Johns theory based on reviews and experience”  Some things spread rapidly  Clinician interest/patient demand (minimally invasiev surgery)  Compelling cost savings (automated testing path)  Some slowly, in patches  Support to prevent admission of high users Which  Some proven but very low uptake Ones?  Do not spread straight from the “research fridge” Why?  Some in spite of –ve evidence 1  Smart IV pumps in ICU (Nuckols et al 2007) 0
  • 11. Research based theory – simple summary Seed Gardener/planting & nurture Climate / soil Product Push> <Pull 3/2/2012 11
  • 12. Bridging the P1 / / P2 chasm  Product  Features of the new better intervention  Comes with credible evidence of effectiveness  Push  Marketing and support  Pull  Services experience a problem this can solve  It fits with values and “makes sense”  Services are capable of adopting and sustaining it - 1 3/2/2012 resources 2
  • 13. Bridging the P2 / / P3 chasm Glen Allen, Virginia - Google Maps Address  From a number of services (P2) to 70% regional or national coverage with >50% adoption of intervention (P3)  Which is most critical here? Vote, 1,2,3 1)Product? 2)Push? 3)Pull? 1 3/2/2012 3
  • 14. What help can research give to “Chasm- Bridgers”? 1 Research based assessment ool – HRET 2 Concepts - Ways of thinking about what and how to spread 3 Categorisation of implementation/spread approaches 1 4
  • 15. 1 Research based assessment tool – HRET 1 5
  • 16. Sections HRET Spread Assessment Tool  Environmental Factors  Innovation Factors  Target Audience Factors  Organizational Factors Spread Readiness Scale:  101-125 Organic, Natural Spread  76-100 Promising Spread Initiative  51 – 75 Challenging Spread Initiative 1  <50 Doomed, Focus on Underlying Issues 6
  • 17. Research into implementation “approaches” Progress so far… Conceptualisation – are there different “approaches” and how do we define/describe? Concepts 1: distinction between a) Treatment and service delivery interventions from b) Implementation - what done to enable providers to change  Note: distinction not useful when implementation involves iterative adaption - testing & revision of 17 intervention (intervention not already proven locally)
  • 18. Example of intervention content Eg CLABSI Bundle: 1 Wash your hands. 2 Clean skin with chlorhexidine. 3. Use maximal barrier precautions. 4. Avoid the femoral site. 5. Ask daily whether the benefits of the line exceed the risks. 1 8
  • 19. Example of Implementation “approach” Breakthrough collaborative eg Michigan Keystone: 1 3/2/2012 9
  • 20. Three Elements Collaborative breakthrough programme  Structure:  Groups and accountability 3 levels: 1regional collaborative organisers, 2 local management, 3 local project team  Systems:  Project team measurement and feedback  Regional support  Steps/methods  Planning, learning sessions & calls, post-collaborative  To plan and change local service, test and revise 2 0
  • 21. Implementation approach = “3S” combination of: 1 Structure:  who is going to help this happen and by when: roles, responsibility, time, accountability 2 Systems:  measurement and feedback 3 Systematic Steps:  methods, actions = systematic ways to enable 2 change 1
  • 22. Different ways of classifying 3) Systematic Step methods?  Professional; Financial strategies; Organizational strategies. Or guidelines (Hysong 2011) 2 3/2/2012 2
  • 23. . So implementation does not just happen? You have to have an infrastructure?  Current channels – professions limited impact, regulation more, financial penalties and rewards - more still. Concepts 3:  Specific intervention implementation infrastructure (eg time limited collaborative for X)  Generic implementation infrastructure : to support any project and continual change  (eg IMC research unit, KP performance improvement 2 units, VA systems design and some QUERI centres)3 3/2/2012
  • 24. Concepts 4: Alignment of context influences  Infrastructure may involve “influencers” which act on different levels of health system  to get the influences at each level to align Eg for CLABSI or readmission  Need “alignment adjusters” to identify influences countering X change and to “sheep dog” the influences  Theory: aligned actions by different levels may be more 2 effective (but feasible?) (context to help implementation) 3/2/2012 4
  • 25. Is this conception of “intervention approach”- (structure, systems, steps/methods) a theory then? What do you think - YES? No? Yes – based on observation of collaborative and other intentional systematic improvement programmes Predictive theory - untested  Hypothesis in play in this field: H1: Some implementation approaches are more suited to some interventions than others  (the “intervention/implementation match” for effective sustained change) 2 3/2/2012 5
  • 26. H1: Match intervention to implementation approach eg if aim to change individual physician prescribing behaviour, then this implementation approach more effective than a collaborative:  Structure: nationally credible researchers, local physician opinion leaders and champions, peer project teams, academic detailers.  Systems: credible existing data banks on prescribing  Systematic steps: training, feedback, academic2 detailing. 6 3/2/2012
  • 27. H1: Match intervention to implementation approach  If implementing a clinical decision support system in an EMR:  Structure: project team, steering committee, senior management sub-group  Systems: Measurement and feedback  Systematic steps: Methods: phased testing, flexiblity in standard screens, etc  If implementing a chronic care model then…. 2 3/2/2012 7
  • 28. H2 : Context match to intervention and implementation approach  Is there a “fit”, and is it “fit to stick”  Internal context: Advances values, norms, objectives, & priorities  External context:  Compatible with regulations, financing and directives 2 3/2/2012 8
  • 29. Part 3 Research Agenda and Methods Covers 3 subjects: Practitioners have questions we are not addressing – next Methods for providing research based answers What are the challenges for us 2 3/2/2012 9
  • 30. Practitioners want this information:  Description: What was the implementation approach? (and the intervention content)  Cost effectiveness: Did it acheive the change cost- effectively? (and did the intervention change reduce costs and make a difference for patients?)  Replicability: in which situations would we expect similar results 3  and which principles should guide design of the0 implementation approach in other situations? 3/2/2012
  • 31. Three research strategies 1 Parallel process and outcome- effectiveness evaluations 2 Theory-based testing or model- revising 3 Integrated research-implementation evaluation 3 See March 8th Cyber seminar 3/2/2012 1
  • 32. Challenges Attitude – practical questions not real science and wont get published – can’t serve two masters Skills to use the methods New research practice Practice based – engaged partnership research Academic promotion and reviewers Financing Shift of financing and reviewers to be more 3 accepting 2 3/2/2012
  • 33. Conclusions Each person write down and then share in the group: 1. These were the main points… 2. This was new or surprising, for me… 3. The most useful idea for my work was… 4. What I would like to find out more about… 3/2/2012 33
  • 34. Resources 3 3/2/2012 4
  • 35. Resources on Johns web site folder  http://public.me.com/johnovr  . 3 3/2/2012 5
  • 36. Resources on Johns web site folder  http://public.me.com/johnovr  Or or https://www.idrive.com - see references at end of PPT Download files from idrive by going to web site: http://www.idrive.com/;  Log in user = jovr pass= anna. THEN use the search field on the right to enter in a word realated to the subject. You will see files on this subject – click on the file you want to download, after entering anna and it will download to your computer. 3 3/2/2012 6
  • 37. References.  . 3 3/2/2012 7
  • 38. DETAILS 3 3/2/2012 8
  • 39. BANK 1mar 3 3/2/2012 9
  • 40. .  Few interventions and innovations are able to cross the project//spread chasm. The fit between the innovation and the adopting service appears critical, but the paradox is that if it fits too well and is likely to be adopted with minor disruption, it may not make much improvement or be much of an innovation. This seminar considers issues in moving an innovation from pilot to phase 1 and phase 2 scale up stages, and ways to carry out actionable research into the strategies, structure4 and steps for spread. 3/2/2012 0
  • 41. It has to be local because  10% of success is local personalities  20% of success is using a change proven elsewhere to improve quality and reduce costs  30% is your implementation (do you have skills, project team capacity, experience?)  40% is nothing to do with you -  whether your context enables implementation and rewards value improvements  Do you get paid for a diagnosis of patient admitted 5 days after discharge with AC SYSTOLIC HRT FAILURE (2008 ICD-9-CM Diagnosis Code 428.21)? 4 1  I patient diagnoised with above during stay – do you get paid?
  • 42. Johns theory based on reviews and experience”  Some things spread rapidly  Clinician interest/patient demand (minimally invasiev surgery)  Compelling cost savings (automated testing path)  Some slowly, in patches  Support to prevent admission of high users Which  Some proven but very low uptake Ones?  Do not spread straight from the “research fridge” Why?  Some in spite of –ve evidence 4  Smart IV pumps in ICU (Nuckols et al 2007) 2
  • 43. The research issues We know less about how to put it into widespread practice… than about what works  Missing, Methods, Attitude/motivation, rewards incentives structure 4 3/2/2012 3
  • 44. Knowledge Translation to everyday clinical practice K Basic BioMedical K Treatment Science K Efficacy Effectiveness In controlled range of patients situation with Translation 1 specific patients Intervention to Translation 2 patients Intervention to range K Implementation RCTs on patients of patients in Effectiveness range of different settings providers to use treatment RCTs or controlled trials on patients Translation 3 Intervention to providers to use the treatment RCTs or controlled trials on Oh, that life were so simple! providers Non-experimental research designs
  • 45. .  . 4 3/2/2012 5
  • 46. .  . 4 3/2/2012 6
  • 47. Conclusions Each person write down and then share in the group: 1. These were the main points… 2. This was new or surprising, for me… 3. The most useful idea for my work was… 4. What I would like to find out more about… 3/2/2012 47

Editor's Notes

  1. The academics view